34 專題探討 • TOPIC INSIGHT 澳大新語 • 2025 UMAGAZINE 32 澳大開發創新納米材料，以提升腫瘤放射免疫治療的療效。 The innovative nanomaterials developed by UM can enhance the efficacy of radiotherapy in cancer treatment 代云路教授（前排中）及其團隊 Prof Dai Yunlu (centre in the front row) and his research team The team has established close collaboration with clinicians to explore the expanded application of nano-drugs in preclinical models, while also securing patent applications and research funding to lay the foundation for future clinical trials. Prof Dai believes that nanomaterials will play a pivotal role in precision treatment, immune regulation, and personalised medicine. He also states that bLDH and PWAI, both independently developed by UM, serve as a novel immunologic adjuvant and a dual-epigenetic reprogramming radiosensitiser, respectively, and that they can offer new, comprehensive treatment strategies for various difficult-to-treat tumours, demonstrating their broad application prospects. Driving the Future of Healthcare With New Materials UM’s pioneering research demonstrates how new materials are spearheading a transformation in medical technology—from bioinspired hydrogel scaffolds that overcome mechanical mismatch, to molecular glue that activates tissue regeneration, and ‘nano-missiles’ that target tumours with precision. These scientific breakthroughs are all built upon a foundation of interdisciplinary collaboration. As these laboratory innovations advance towards clinical applications, UM’s intellectual achievements will undoubtedly become a powerful force in safeguarding human health.
RkJQdWJsaXNoZXIy NzM0NzM2